Reacción #2329010
ord-0171bb6dfd914455bd397d0af991b7a6
Ecuación de reacción
Reactivos
Disolventes
Condiciones de reacción
Tratamiento posterior
- 1Otrovial fitted with a septa
- 2Otrocap
- 3workup.STIRRINGThe reaction was stirred at 5° C. for 3 h
- 4Temperaturato warm to room temperature
- 5workup.STIRRINGstirred overnight at room temperature
- 6TemperaturaThe reaction mixture was cooled to 0° C.
- 7Otroquenched with 2 mL of water
- 8workup.ADDITIONdiluted with 2 mL of methyl tert-butyl ether
- 9workup.STIRRINGThe vial was shaken vigourously
- 10Otroto separate
- 11OtroThe aqueous layer was removed with a pipette
- 12Lavadothe organic layer washed with another 2 mL of water
- 13SecadoThe organic phase was dried (MgSO4)
- 14Concentraciónconcentrated in vacuo
- 15Otrothe residue purified by reverse phase HPLC (Shimadzu)
Procedimiento
A 1.0 M solution of potassium t-butoxide in t-butanol (0.3 mL) was added to a 8 mL vial fitted with a septa cap containing 0.3 mL of dry THF and 30 mg (0.3 mmoles) of 3-hydroxy cylcopentanol at 5° C. The mixture was stirred for 0.5 h at 5° C., after which time 0.3 mL of a 1.0 M THF solution of 4-fluoro-2-chloro-benzonitrile was added. The reaction was stirred at 5° C. for 3 h and then allowed to warm to room temperature and stirred overnight at room temperature. The reaction mixture was cooled to 0° C., and quenched with 2 mL of water, diluted with 2 mL of methyl tert-butyl ether. The vial was shaken vigourously and the phases allowed to separate. The aqueous layer was removed with a pipette, and the organic layer washed with another 2 mL of water. The organic phase was dried (MgSO4), concentrated in vacuo, and the residue purified by reverse phase HPLC (Shimadzu) to give 36 mg (52%) of the title compound. GC/MS: 235 (M/Z for C13H14ClNO).